AONC - aoncology.com Net Sales Margin

American Oncology Network, Inc. (AONC) - corporate logo

American Oncology Network (AONC) optimizes its business processes by outsourcing IT tasks to external partners through strict SLAs. The efficiency of logistics hubs and the control of drug supplies support high profitability. The commercial net margin indicates stable earnings, with the value recorded at -2.00. The company's revenues are based on clinic administration, drug sales, and technological support for private oncology practices.

aoncology.com (AONC) - Return on Sales by Net Profit from 02/21/2024 to 08/04/2024

Comprehensive metric breakdowns and analytics for American Oncology Network Inc (AONC)

- market value and analyst target forecast:
Summary company analytics:American Oncology Network
Manufactured product of American Oncology Network, Inc.

American Oncology Network (AONC) is actively expanding its clinic network while optimizing internal processes to meet public market requirements. This metric determines the share of net profit in every dollar of revenue, measuring the overall efficiency of the business. An analysis of the commercial net margin allows for an assessment of the issuer's real competitiveness within the saturated US market. Positive dynamics confirm the successful scaling of the operating model. The steady growth of this indicator strengthens institutional investors' confidence in the company's capital.

Analysis of competing companies

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|WHWK: Net Sales Margin|TScan Therapeutics (TCRX) - Net Sales Margin|Net Margin Champions Oncology|Net Margin XBIT|Net Sales Margin CVM|Return on Sales by Net Profit OS Therapies Inc. OSTX|Net Margin Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Net Margin|ANL - Net Margin|Net Margin verupharma.com|TPST: Net Sales Margin|XLO - Company Sales Margin|Net Margin Renovaro|Net Sales Margin muraloncology.com|Net Sales Margin KAPA|Company Sales Margin OnKure Therapeutics, Inc.|Net Sales Margin GDTC (w2.cytomed.sg)|CRIS - Return on Sales by Net Profit|Apollomics - Net Sales Margin|Tharimmune Corp (THAR) - Return on Sales by Net Profit|ADVB: Net Sales Margin|Return on Sales by Net Profit Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Net Sales Margin|Net Return on Sales SBFM (Sunshine Biopharma)|Net Margin Xenetic Bio (XBIO)|Net Margin SLRX (Salarius Pharma)|Kitov Pharma - Return on Sales by Net Profit|BeiGene, Ltd. (BGNE) - Net Margin|Checkpoint Therapeutics Inc. - Net Sales Margin|Net Profit Rate ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Return on Sales by Net Profit|Ikena Oncology, Inc. - Net Profit Rate|Return on Sales by Net Profit NTBL|VIRX: Net Profit Rate|Net Margin MorphoSys Corporation (MOR)|NAYA - Net Margin|Net Sales Margin AAPGV (Ascentage)